SCHEMBL10328527

SCHEMBL10328527

Cc1cc(Cc2ccc(NS(=O)(=O)c3ccc(Cl)s3)cc2)c2cc(F)ccc2n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.53
▸ MAPT P10636 3/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ PTPN1 P18031 9/20 0.43
▸ PTPN2 P17706 8/20 0.43
▸ PTPN5 P54829 8/20 0.43
▸ HSPD1 P10809 6/20 0.43
▸ HSPE1 P61604 6/20 0.43
▸ KIT P10721 1/20 0.42
▸ PABPC1 P11940 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ CASP3 P42574 2/20 0.42
▸ SENP8 Q96LD8 2/20 0.42
▸ SENP7 Q9BQF6 2/20 0.42
▸ SENP6 Q9GZR1 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1591669 0.82 SMN1; SMN2 (0.47) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL13667269 0.81 RORC (0.52) ALDH1A1HPGDHTTKITSMN1; SMN2
SCHEMBL10328504 0.78 PGR (0.48) MAPTALDH1A1HTTPTPN1PTPN2
SCHEMBL10328517 0.78 ACLY (0.44) LMNAMEN1KMT2AALDH1A1HTT
SCHEMBL10328523 0.77 PGR (0.47) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL7573917 0.73 MAPT (0.64) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL10328495 0.72 TP53 (0.43) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL10328534 0.70 AGTR1 (0.44) LMNAMAPTMEN1KMT2AHTT
SCHEMBL19334352 0.69 LMNA (0.67) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL13059432 0.66 KDM4E (0.47) ALDH1A1HTTSMN1; SMN2CASP3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262772-B1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS MAX PLANCK GESELLSCHAFT (DE) 2012-07-18 — — EP disclosed
WO-2009127417-A1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2009-10-22 — — WO disclosed
Send feedback